Hoey Investments’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-231
Closed -$8.76K 379
2024
Q4
$8.76K Hold
231
﹤0.01% 215
2024
Q3
$9.44K Hold
231
﹤0.01% 211
2024
Q2
$9.44K Hold
231
﹤0.01% 211
2024
Q1
$9.57K Sell
231
-30
-11% -$1.26K ﹤0.01% 211
2023
Q4
$10.6K Hold
261
﹤0.01% 203
2023
Q3
$10.2K Sell
261
-900
-78% -$35.8K ﹤0.01% 210
2023
Q2
$47.2K Sell
1,161
-950
-45% -$39.1K 0.02% 131
2023
Q1
$88.4K Sell
2,111
-253
-11% -$10.6K 0.03% 110
2022
Q4
$103K Sell
2,364
-1,995
-46% -$84.8K 0.04% 102
2022
Q3
$169K Buy
+4,359
New +$186K 0.07% 95

Other funds holding BME

Hoey Investments's BME Position: Q1 2025 in Review

Hoey Investments sold out of BlackRock Health Sciences Trust (BME) in Q1 2025, closing a stake of 231 shares — an estimated $8.76K sold.

Hoey Investments first reported a position in BME in Q3 2022 and held it in 10 quarters. The position peaked at $169K in Q3 2022. 67 funds tracked by Wall St. Rank hold BME as of Q1 2025.

  • Hoey Investments reported no remaining BlackRock Health Sciences Trust position as of Q1 2025 after selling out during the quarter.
  • Hoey Investments sold 231 BlackRock Health Sciences Trust shares in Q1 2025, an estimated $8.76K.
  • Hoey Investments first reported a position in BlackRock Health Sciences Trust in Q3 2022 and held it in 10 quarters.
  • Hoey Investments's BlackRock Health Sciences Trust position peaked at $169K in Q3 2022.
  • 67 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2025.

Based on Hoey Investments's 13F filing for Q1 2025, filed 16 Apr 2025.